Psyence Biomedical Ltd is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
PBM stock price ended at $2.81 on Jueves, after dropping 5.07%
On the latest trading day Feb 12, 2026, the stock price of PBM fell by 5.07%, dropping from $2.87 to $2.81. During the session, the stock saw a volatility of 10.26%, with prices oscillating between a daily low of $2.73 and a high of $3.01. On the latest trading day, the trading volume for PBM rose by 19.9K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 82.5K shares were traded, with a market value of approximately $5.2M.
Señales Técnicas de PBM
Resumen de Señales Técnicas
Señales de compra 3
Señales Neutras 0
Señales de venta 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
PBM actualmente presenta 3 señales de compra y 4 señales de venta. La acción ha estado en una tendencia bajista desde 12:00 AM, con un cambio total en el precio de -11.64% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Sell para el mediano plazo.
Señales alcistas/bajistas para PBM
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para PBM. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.